Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum

Molecular Human Reproduction

Volumn 14, Issue 5, 2008, Pages 301-307

  Ferreira, M C ^a,b   Witz, C A ^a   Hammes, L S ^a   Kirma, N ^a   Petraglia, F ^b   Schenken, R S ^a   Reis, F M ^b,c  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

Activin A; Cadherins; Endometriosis; Follistatin; Inhibin A

Indexed keywords

ACTIVIN A; FOLLISTATIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; UVOMORULIN;

ARTICLE; CELL ADHESION; CELL ASSAY; CELL CULTURE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM CELL; PERITONEAL MESOTHELIAL CELL; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

ACTIVIN RECEPTORS; ACTIVINS; ANTIGENS, CD; CADHERINS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ENDOMETRIUM; EPITHELIAL CELLS; FEMALE; HUMANS; MODELS, BIOLOGICAL; PERITONEUM; RNA, MESSENGER; STROMAL CELLS;

EID: 44949144789     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gan016     Document Type: Article

References (49)

1. Abdallah MA, Kang S, Nakajima ST, Gercel-Taylor C. Matrix metalloproteinase-9 activity in the plasma of patients after surgical resection of endometriomas. Fertil Steril 2006;85:1847-1848.
2. Béliard A, Donnez J, Nisolle M, Foidart JM. Localization of laminin, fibronectin. E-cadherin, and integrins in endometrium and endometriosis. Fertil Steril 1997;67:266-272.
3. Bonnet-Duquennoy M, Abaibou H, Tailhardat M, Lazou K, Bosset S, Le Varlet B, Cleuziat P, Kurfürst R. Study of housekeeping gene expression in human keratinocytes using OLISA, a long-oligonucleotide microarray and q RT-PCR. Eur J Dermatol 2006;16:136-140.
4. Caniggia I, Lye SJ, Cross JC. Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology 1997;138 3976-3986.
5. Catalano RD, Critchley HO, Heikinheimo O, Baird DT, Hapangama D, Sherwin JR, Charnock-Jones DS, Smith SK, Sharkey AM. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod 2007:13:641-654.
6. Collette T, Maheux R, Mailloux J, Akoum A. Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis. Hum Reprod 2006;21:3059-3067.
7. de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K, van den Eijnden-van Raaij AJ. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type ii receptors. Mol Cell Endocrinol 1996;116 105-114.
8. Dechaud H, Witz CA, Montoya-Rodriguez IA, Degraffenreid LA, Schenken RS. Mesothelial cell-associated hyaluronic acid promotes adhesion of endometrial cells to mesothelium. Fertil Steril 2001;76 1012-1018.
9. Florio P, Luisi S, Vigano P, Busacca M, Fadalti M, Genazzani AR, Petraglia F. Healthy women and patients with endometriosis show high concentrations of inhibin a, inhibin b, and activin a in peritoneal fluid throughout the menstrual cycle. Hum Reprod 1998;13 2606-2611.
10. Florio P, Severi FM, Luisi S, Ciarmela P, Calonaci G, Cobellis L, Petraglia F. Endometrial expression and secretion of activin a, but not follistatin, increase in the secretory phase of the menstrual cycle. J Soc Gynecol Investig 2003;10:237-243.
11. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule e-cadherin. Am J Pathol 1997;150:461-467.
12. Gray PC, Bilezikjian LM, Vale W. Antagonism of activin by inhibin and inhibin receptors: A functional role for betaglycan. Mol Cell Endocrinol 2002;188:254-260.
13. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984;64:151-154.
14. Jones RL, Findlay JK, Farnworth PG, Robertson DM, Wallace E, Salamonsen LA. Activin a and inhibin a differentially regulate human uterine matrix metalloproteinases: Potential interactions during decidualization and trophoblast invasion. Endocrinology 2006;147:724-732.
15. Jones RL, Salamonsen LA, Critchley HO, Rogers PA, Affandi B, Findlay JK. Inhibin and activin subunits are differentially expressed in endometrial cells and leukocytes during the menstrual cycle, in early pregnancy and in women using progestin-only contraception. Mol Hum Reprod 2000;6:1107-1117.
16. Jones RL, Salamonsen LA, Zhao YC, Ethrier JF, Drummond AE, Findlay JK. Expression of activin receptors, follistatin and betaglycan by human endometrial stromal cells; consistent with a role for activins during decidualization. Mol Hum Reprod 2002;8:363-374.
17. Kirk D, Irwin JC. Normal human endometrium in cell culture. Methods Cell Biol 1980;21B:51-77.
18. Lebrun A Vale WW. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type i and type ii activin receptors and human erythroid differentiation. Mol Cell Biol 1997;17:1682-1691.
19. Leung PH, Salamonsen LA, Findlay JK. Immunolocalization of inhibin and activin subunits in human endometrium across the menstrual cycle. Hum Reprod 1998;13:3469-3477.
20. Ling N, Ying SY, Ueno N, Shimasaki S, Esch F, Hotta M, Guillemin R. Pituitary fsh is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature 1986;321:779-782.
21. Liu DT, Hitchcock A. Endometriosis: Its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol 1986;93:859-862.
22. Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS. A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril 2005;84:16-21.
23. Maguer-Satta V, Forissier S, Bartholin L, Martel S, Jeanpierre S, Bachelard E, Rimokh R. A novel role for fibronectin type I domain in the regulation of human hematopoietic cell adhesiveness through binding to follistatin domains of FLRG and follistatin. Exp Cell Res 2006; 312: 434-442.
24. Mathews LS, Vale WW. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 1991;65:973-982.
25. Mathews LS, Vale WW. Characterization of type ii activin receptors. Binding, processing, and phosphorylation. J Biol Chem 1993;268 19013-19018.
26. Mathews LS, Vale WW, Kintner CR. Cloning of a second type of activin receptor and functional characterization in xenopus embryos. Science 1992;255:1702-1705.
27. Merviel P, Degeorges A, Salat-Baroux J, Calvo F. Normal human endometrial cells in culture: Characterization and immortalization of epithelial and stromal cells by SV 40 large T antigen. Biol Cell 1995;84: 187-193.
28. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V, Friese K. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: An immunohistochemical analysis. Gynecol Oncol 2004;93:92-97.
29. Nair AS, Nair HB, Lucidi RS, Kirchner AJ, Schenken RS, Tekmal RR, Witz CA. Modeling the early endometriotic lesion: Mesothelium-endometrial cell co-culture increases endometrial invasion and alters mesothelial and endometrial gene transcription. Fertil Steril 2007 (Epub ahead of print).
30. Otani T, Minami S, Yamoto M, Umesaki N. Production of activin a in hyperplasia and adenocarcinoma of the human endometrium. Gynecol Oncol 2001;83:31-38.
31. Petraglia F, Florio P, Luisi S, Gallo R, Gadducci A, Vigano P, Di Blasio AM, Genazzani AR, Vale W. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin a in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 1998;83:1194-1200.
32. Poncelet C, Leblanc M, Walker-Combrouze F, Soriano D, Feldmann G, Madelenat P, Scoazec JY, Darai E. Expression of cadherins and cd44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet Gynecol Scand 2002;81:195-203.
33. Ramos JW, Whittaker CA, DeSimone DW. Integrin-dependent adhesive activity is spatially controlled by inductive signals at gastrulation. Development 1996;122:2873-2883.
34. Reis FM, Di Blasio AM, Florio P, Ambrosini G, Di Loreto C, Petraglia F. Evidence for local production of inhibin a and activin a in patients with ovarian endometriosis. Fertil Steril 2001;75:367-373.
35. Rombauts L, Donoghue J, Cann L, Jones RL, Healy DL. Activin-a secretion is increased in the eutopic endometrium from women with endometriosis. Aust N Z J Obstet Gynaecol 2006;46:148-153.
36. Sampson JA. Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927;14:422-469.
37. Starzinski-Powitz A, Gaetje R, Zeitvogel A, Kotzian S, Handrow-Metzmacher H, Herrmann G, Fanning E, Baumann R. Tracing cellular and molecular mechanisms involved in endometriosis. Hum Reprod Update 1998;4: 724-729.
38. Starzinski-Powitz A, Handrow-Metzmacher H, Kotzian S. The putative role of cell adhesion molecules in endometriosis: Can we learn from tumour metastasis? Mol Med Today 1999;5:304-309.
39. Torres PB, Florio P, Ferreira MC, Torricelli M, Reis FM, Petraglia F. Deranged expression of follistatin and follistatin-like protein in women with ovarian endometriosis. Fertil Steril 2007;88:200-205.
40. Tsuchida K, Mathews LS, Vale WW. Cloning and characterization of a transmembrane serine kinase that acts as an activin type i receptor. Proc Natl Acad Sci USA 1993;90:11242-11246.
41. Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW. Inactivation of activin-dependent transcription by kinase-deficient activin receptors. Endocrinology 1995;136:5493-5503.
42. Tsuchiya B, Sato Y, Kameya T, Okayasu I, Mukai K. Differential expression of N-cadherin and E-cadherin in normal human tissues. Arch Histol Cytol 2006;69:135-145.
43. Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: A single-chain mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987;84:8282-8286.
44. Vale W, Rivier J, Vaughan J, McClintock R, Corrigan A, Woo W, Karr D, Spiess J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986;321 776-779.
45. Witz CA, Allsup KT, Montoya-Rodriguez IA, Vaughn SL, Centonze VE, Schenken RS. Culture of menstrual endometrium with peritoneal explants and mesothelial monolayers confirms attachment to intact mesothelial cells. Hum Reprod 2002;17:2832-2838.
46. Witz CA, Cho S, Centonze VE, Montoya-Rodriguez IA, Schenken RS. Time series analysis of transmesothelial invasion by endometrial stromal and epithelial cells using three-dimensional confocal microscopy. Fertil Steril 2003;79:770-778.
47. Wrana JL, Attisano L. The smad pathway. Cytokine Growth Factor Rev 2000;11:5-13.
48. Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M. N-cadherin is regulated by activin a and associated with tumor aggressiveness in esophageal carcinoma. Clin Cancer Res 2004;10:5702-5707.
49. Zeitvogel A, Baumann R, Starzinski-Powitz A. Identification of an invasive, n-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model. Am J Pathol 2001;159 1839-1852.